Form DEFA14A ACELRX PHARMACEUTICALS

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.    )

 

Filed by the Registrant	☑
Filed by a Party other than the Registrant	☐

        

Check the appropriate box:

 

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☑	Definitive Additional Materials

☐	Soliciting Material Pursuant to § 240.14a-12

 

ACELRX PHARMACEUTICALS, INC.

---

(Name of Registrant as Specified In Its Charter)

 

---

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box)

 

☑	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Scorpio Gold Provides Q1 Corporate Update and 2024 Outlook
• Johnson & Johnson Reports Q1 2024 Results
• Hybrid Power Solutions to Complete Delivery of Fuel-Free Power Packs to California-Based Utility